Papers - TOKUDA Emi
-
Usefulness of urine dipstick test in the management of adverse events associated with immune checkpoint inhibitors.
Izumi K, Iyoda T, Yokota A, Kanno M, Hoshi M, Tokuda E, Sasaki E, Kanazawa K, Kuroda J, Saji S.
Support Care Cancer. 32 ( 11 ) 735 2024.10
-
Ⅱバイオロジー,基礎研究の進歩 6 女性ホルモン依存性の分子機構とその耐性獲得
徳田 恵美
日本臨床 82 ( 増刊6 ) 64 - 70 2024.9（ ISSN:0047-1852 ）
-
Association between specific human leukocyte antigen alleles and development of thyroid immune-related adverse event.
Sasaki E, Natori Y, Tokuda E, Kimura-Tsuchiya R, Suga J, Kanazawa K, Koguchi T, Kikuchi N, Okabe N, Murono S, Tachibana K, Soeda S, Shimabukuro M, Saji S.
Immunotherapy. 2024.6
-
Sasaki E, Natori Y, Tokuda E, Kimura-Tsuchiya R, Suga J, Kanazawa K, Koguchi T, Kikuchi N, Okabe N, Murono S, Tachibana K, Soeda S, Shimabukuro M, Saji S
Immunotherapy 1 - 10 2024.6（ ISSN:1750-743X ）
-
The Impact of Being Underweight on the Prognosis of Older Patients With Early Breast Cancer.
Ishizuka Y, Horimoto Y, Morita M, Kawamura Y, Sekine K, Obayashi S, Kojima Y, Tokuda E, Higuchi T, Shimomura A.
Cancer Diagn Progn. 3 ( 6 ) 678 - 686 2023.11
-
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition.
Terada M, Ito A, Kikawa Y, Koizumi K, Naito Y, Shimoi T, Ishihara M, Yamanaka T, Ozaki Y, Hara F, Nakamura R, Hattori M, Miyashita M, Kondo N, Yoshinami T, Takada M, Matsumoto K, Narui K, Sasada S, Iwamoto T, Hosoda M, Takano Y, Oba T, Sakai H, Murakami A, Higuchi T, Tsuchida J, Tanabe Y, Shigechi T, Tokuda E, Harao M, Kashiwagi S, Mase J, Watanabe J, Nagai SE, Yamauchi C, Yamamoto Y, Iwata H, Saji S, Toyama T.
Breast Cancer. 2023.11
-
Natori Y, Suga J, Tokuda E, Tachibana K, Imai J, Honma R, Azami Y, Noda M, Sasaki E, Watanabe S, Ohtake T, Saji S.
Cancers 15 ( 2 ) 539 - 539 2023.1（ ISSN:2072-6694 ）
-
Successful management of pelvic recurrence of MSI-High endometrial cancer by total pelvic exenteration followed by administration of pembrolizumab:A case report.
Kojima M, Soeda S, Okabe C, Sato T, Kamo N, Ueda M, Endo Y, Nomura S, Tokuda E, Furukawa S, Kataoka M, Fujita S, Saji S, Watanabe T, Fujimori K.
Fukushima J Med Sci. 15 ( 2 ) 539 2022.12
-
Is adjuvant chemotherapy necessary in older patients with breast cancer?
Morita M, Shimomura A, Tokuda E, Horimoto Y, Kawamura Y, Ishizuka Y, Sekine K, Obayashi S, Kojima Y, Uemura Y, Higuchi T.
Breast Cancer. 29 ( 3 ) 498 - 506 2022.5（ ISSN:1340-6868 ）
-
Everolimus+Exemestane療法後に腫瘍崩壊症候群をきたした進行乳癌の一例
竹村 真生子, 岡崎 護, 羽成 直行, 徳田 恵美, 田辺 真彦, 林 嗣博, 水谷 知央, 林 孝朗, 中村 優飛, 根本 悠里, 佐久間 芽衣, 叶多 諒, 萩尾 浩太郎, 絹田 俊爾, 山口 佳子, 輿石 直樹
福島医学雑誌 71 ( 1 ) 35 - 40 2021.4（ ISSN:0016-2582 ）
-
Everolimus+Exemestane療法後に腫瘍崩壊症候群をきたした進行乳癌の一例
竹村 真生子, 岡崎 護, 羽成 直行, 徳田 恵美, 田辺 真彦, 林 嗣博, 水谷 知央, 林 孝朗, 中村 優飛, 根本 悠里, 佐久間 芽衣, 叶多 諒, 萩尾 浩太郎, 絹田 俊爾, 山口 佳子, 輿石 直樹
福島医学雑誌 71 ( 1 ) 35 - 40 2021.4（ ISSN:0016-2582 ）
-
Risk of immunotherapy-related narcolepsy in genetically predisposed patients: a case report of narcolepsy after administration of pembrolizumab.
Natori Y, Sasaki E, Soeda S, Furukawa S, Azami Y, Tokuda E, Kanbayashi T, Saji S
Journal for immunotherapy of cancer 8 ( 2 ) 2020.10
-
Decreased ER dependency after acquired resistance to CDK4/6 inhibitors
Iida Masafumi, Toyosawa Daichi, Nakamura Misato, Tsuboi Kouki, Tokuda Emi, Niwa Toshifumi, Ishida Takanori, Hayashi Shin-ichi
Breast Cancer 27 ( 5 ) 963 - 972 2020.9（ ISSN:1340-6868 ）
-
Microsatellite instability and mismatch repair protein expressions in lymphocyte-predominant breast cancer.
Horimoto Yoshiya, Hlaing May Thinzar, Saeki Harumi, Kitano Shigehisa, Nakai Katsuya, Sasaki Ritsuko, Kurisaki-Arakawa Aiko, Arakawa Atsushi, Otsuji Naomi, Matsuoka Shuji, Tokuda Emi, Arai Masami, Saito Mitsue
Cancer Science 111 ( 7 ) 2647 - 2654 2020.7（ ISSN:1347-9032 ）
-
分子標的治療薬の副作用と支持療法 CDK4/6阻害薬
徳田 恵美
腫瘍内科 25 ( 3 ) 257 - 264 2020.3
-
食道狭窄をきたした高齢者転移性乳癌に集学的治療が著効した1例
魚森 俊喬, 徳田 恵美, 堀本 義哉, 齊藤 光江
日本外科系連合学会誌 44 ( 6 ) 1031 - 1035 2019.12（ ISSN:0385-7883 ）
-
Impact of circulating tumour cells on survival of eribulin-treated patients with metastatic breast cancer.
Ito M, Horimoto Y, Tokuda E, Murakami F, Uomori T, Himuro T, Nakai K, Orihata G, Iijima K, Saito M.
Med Oncol. 36 ( 10 ) 89 2019.9
-
Impact of circulating tumour cells on survival of eribulin-treated patients with metastatic breast cancer.
Ito M, Horimoto Y, Tokuda E, Murakami F, Uomori T, Himuro T, Nakai K, Orihata G, Iijima K, Saito M
Medical oncology (Northwood, London, England) 36 ( 10 ) 89 2019.9（ ISSN:1357-0560 ）
-
The p21 levels have the potential to be a monitoring marker for ribociclib in breast cancer.
Iida M, Nakamura M, Tokuda E, Toyosawa D, Niwa T, Ohuchi N, Ishida T, Hayashi SI
Oncotarget. 10 ( 47 ) 4907 - 4918 2019.8
-
【エストロゲン受容体陽性転移乳癌の薬物療法】CDK4/6阻害薬
徳田 恵美, 佐治 重衡
日本内分泌外科学会誌 36 ( 2 ) 101 - 106 2019.6
-
【エストロゲン受容体陽性転移乳癌の薬物療法】CDK4/6阻害薬
徳田 恵美, 佐治 重衡
日本内分泌外科学会誌 36 ( 2 ) 101 - 106 2019.6
-
Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot study.
Horimoto Y, Tokuda E, Murakami F, Uomori T, Himuro T, Nakai K, Orihata G, Iijima K, Togo S, Shimizu H, Saito M.
J Transl Med. 16 ( 1 ) 287 2018.10
-
Overcoming the Adverse Effects of Everolimus to Achieve Maximum Efficacy in the Treatment of Inoperable Breast Cancer: A Review of 11 Cases at Our Hospital
Yoshida-Ichikawa Y, Tanabe M, Tokuda E, Shimizu H, Horimoto Y, Miura K, Saito M.
Case Rep Oncol. 11 ( 2 ) 511 - 520 2018.7
-
Predictive markers for efficacy of everolimus plus exemestane in patients with luminal HER2-negative metastatic breast cancer.
Okazaki M, Horimoto Y, Tanabe M, Ichikawa Y, Tokuda E, Arakawa A, Kobayashi T, Saito M.
Med Oncol. 35 ( 4 ) 48 2018.3
-
CDK6 might be a key factor for efficacy of CDK4/6 inhibitor and the hormone sensitivity following acquired resistance
Iida Masafumi, Nakamura Misato, Tokuda Emi, Niwa Toshifumi, Ishida Takanori, Hayashi Shin-ichi
CANCER RESEARCH 78 ( 4 ) 2018.2（ ISSN:0008-5472 ）
-
Effects of PI3K inhibitors on endocrine-resistant cell lines and differences in the characteristics of ER positive breast cancer cells after acquired resistance to the inhibitors
Tokuda Emi, Komatsu Takayuki, Sasaki Shunta, Tsuboi Kouki, Nakamura Misato, Iida Masafumi, Niwa Toshifumi, Saito Mitsue, Hayashi Shin-Ichi
CANCER RESEARCH 78 ( 4 ) 2018.2（ ISSN:0008-5472 ）
-
MESENCHYMAL CIRCULATING TUMOUR CELL ANALYSIS TO PREDICT EFFICACY OF ERIBULIN FOR METASTATIC BREAST CANCER PATIENTS
Yoshiya Horimoto, Emi Tokuda, Fumi Murakami, Katsuya Nakai, Hideo Shimizu, Mitsue Saito
BREAST 36 S40 - S41 2017.11（ ISSN:0960-9776 ）
-
Differences in Ki67 expressions between pre- and post-neoadjuvant chemotherapy specimens might predict early recurrence of breast cancer.
Tokuda E, Horimoto Y, Arakawa A, Himuro T, Senuma K, Nakai K, Saito M.
Hum Pathol. 63 40 - 45 2017.5
-
【乳癌学-最新の診断と治療-】 乳癌の分子生物学と発症機序 乳癌のサブタイプ 分子機構と薬物療法概論 エストロゲン依存性乳癌の分子機構と内分泌療法
林 慎一, 徳田 恵美
日本臨床 75 ( 増刊3 ) 112 - 117 2017.4（ ISSN:0047-1852 ）
-
ホルモン療法の感受性マーカー
徳田 恵美, 林 慎一
がん分子標的治療 15 ( 1 ) 66 - 71 2017.3（ ISSN:1347-6955 ）
-
Tumor marking for breast-conserving surgery of non-palpable early breast cancer presenting microcalcifications
M. Mori, E. Tokuda, Y. Horimoto, T. Uomori, F. Murakami, M. Tanabe, A. Shiraishi, A. Arakawa, K. Iijima, M. Saito
BREAST 32 S119 - S119 2017.3（ ISSN:0960-9776 ）
-
Activated Caspase 3 Expression in Remnant Disease After Neoadjuvant Chemotherapy May Predict Outcomes of Breast Cancer Patients.
Himuro T, Horimoto Y, Arakawa A, Matsuoka J, Tokuda E, Tanabe M, Saito M.
Ann Surg Oncol. 23 ( 7 ) 2235 - 2241 2016.7
-
Caspase 3 expression in remnant disease after neo-adjuvant chemotherapy may predict outcomes of breast cancer patients
T. Himuro, Y. Horimoto, A. Arakawa, E. Tokuda, M. Tanabe
EUROPEAN JOURNAL OF CANCER 57 S43 - S43 2016.4（ ISSN:0959-8049 ）
-
Menstrual cycle could affect Ki67 expression in estrogen receptor-positive breast cancer patients.
Horimoto Y, Arakawa A, Tanabe M, Kuroda K, Matsuoka J, Igari F, Himuro T, Yoshida Y, Tokuda E, Shimizu H, Hino O, Saito M
J Clin Pathol. 68 ( 10 ) 825 - 829 2015.10
-
乳癌における上皮間葉転換 治療標的としての臨床応用の可能性
猪狩 史江, 堀本 義哉, 吉田 悠子, 徳田 恵美, 清水 秀穂, 田辺 真彦, 齊藤 光江
乳癌の臨床 30 ( 3 ) 229 - 236 2015.6（ ISSN:0911-2251 ）
-
Application of a 70-Gene Expression Profile to Japanese Breast Cancer Patients.
Shimizu H, Horimoto Y, Arakawa A, Sonoue H, Kurata M, Kosaka T, Nakai K, Himuro T, Tokuda E, Takahashi Y, Taira F, Ito M, Abe I, Senuma K, Stork-Sloots L, de Snoo F, Saito M
Mol Clin Oncol 10 ( 2 ) 118 - 122 2015.4
-
Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases,
Horimoto Y, Arakawa A, Harada-Shoji N, Sonoue H, Yoshida Y, Himuro T, Igari F, Tokuda E, Mamat O, Tanabe M, Hino O, Saito M
Br J Cancer, 112 ( 2 ) 345 - 351 2015.1
-
Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer.
Horimoto Y, Arakawa A, Tanabe M, Sonoue H, Igari F, Senuma K, Tokuda E, Shimizu H, Kosaka T, Saito M.
BMC Cancer. 14 550 2014.7
-
【腹部救急疾患に対する内視鏡外科手術】 医原性大腸穿孔に対する腹腔鏡下手術
吉川 征一郎, 福永 正氣, 李 慶文, 永仮 邦彦, 菅野 雅彦, 須田 健, 飯田 義人, 伊藤 嘉智, 大内 昌和, 勝野 剛太郎, 徳田 恵美, 平崎 憲範, 呉 一眞, 東 大輔
日本腹部救急医学会雑誌 33 ( 1 ) 55 - 59 2013.1（ ISSN:1340-2242 ）
-
Estrogen receptor-α directly regulates sensitivity to paclitaxel in neoadjuvant chemotherapy for breast cancer.
Tokuda E, Seino Y, Arakawa A, Saito M, Kasumi F, Hayashi S, Yamaguchi Y.
Breast Cancer Res Treat. 133 ( 2 ) 427 - 436 2012.6
-
Predictive value of MGMT, hMLH1, hMSH2 and BRCA1 protein expression for pathological complete response to neoadjuvant chemotherapy in basal-like breast cancer patients.
Nakai K, Mitomi H, Alkam Y, Arakawa A, Yao T, Tokuda E, Saito M, Kasumi F.
Cancer Chemother Pharmacol. 69 ( 4 ) 923 - 930 2012.4
-
【腹腔鏡下手術に伴う偶発症への対応】腹腔鏡下手術における術中出血に対する対処
吉川征一郎, 福永正氣, 李慶文, 永仮邦彦, 菅野雅彦, 須田健, 飯田義人, 伊藤嘉智, 大内昌和, 勝野剛太郎, 徳田恵美, 平崎憲範, 夕部由規謙, 須貝歩
日本腹部救急医学会雑誌 32 ( 1 ) 43 - 47 2012.1
-
CA19-9産生乳癌の1例
徳田恵美、阿部郁子、三浦弘善、堀本義哉、荒川 敦、白石昭彦, 齊藤 光江, 霞 富士雄
乳癌の臨床 26 ( 4 ) 481 - 485 2011.8
-
Significance of HER2 protein examination in ductal carcinoma in situ.
Horimoto Y, Tokuda E, Arakawa A, Kosaka T, Saito M, Kasumi F.
J Surg Res. 167 ( 2 ) e205 - e210 2011.5
-
無症状の乳癌術後患者に対する骨シンチグラフィについての検討
堀本 義哉, 徳田 恵美, 白石 昭彦, 中川 智恵, 小坂 泰二郎, 齊藤 光江, 霞 富士雄
乳癌の臨床 25 ( 3 ) 315 - 320 2010.7
-
回腸憩室穿通による後腹膜膿瘍の1手術例
徳田恵美, 杉崎勝好, 青木文夫, 保坂晃弘, 日吉雅也, 正木幸善.
日本臨床外科学会雑誌 70 ( 7 ) 2170 - 2173 2009.7
-
直腸癌術後孤立性副腎転移の1例
徳田恵美, 板東隆文, 永岡栄, 杉崎勝好, 正木幸善, 武村民子.
日本臨床外科学会雑誌 66 ( 11 ) 2802 - 2806 2005.11
-
A case of multiple hepatic and peritoneal metastases from colon cancer responding to oral UFT+leucovorin chemotherapy
Kiyoko Asai, Toyoki Fujita, Yuki Nakamura, Emi Tokuda, Masaya Hiyoshi, Fumio Aoki, Katsuyoshi Sugizaki, Yukiyoshi Masaki
32 ( 12 ) 1959 - 1961 2005.11
-
分子標的としてのAktを介したシグナル伝達
徳田恵美, 藤田直也, 鶴尾隆.
治療学 38 ( 12 ) 1327 - 1331 2004.12